VEGF released from a fibrin biomatrix increases VEGFR-2 expression and improves early outcome after ischaemia-reperfusion injury

Abstract

Skeletal ischaemia-reperfusion (I-R) injury may influence patient outcome after severe vascular trauma or clamping of major vessels. The aim of this study was to observe whether locally applied vascular endothelial growth factor (VEGF) in fibrin could induce the expression of VEGF-receptor-2 (VEGFR-2) and improve the outcome after I-R injury. Transgenic mice expressing VEGFR-2 promoter-controlled luciferase were used for the assessment of VEGFR-2 expression. Ischaemia was induced for 2 h by a tension-controlled tourniquet to the hind limb, followed by 24 h of reperfusion. The animals were locally injected subcutaneously with fibrin sealant containing 20 or 200 ng VEGF; control animals received no treatment or fibrin sealant application. In vivo VEGFR-2 expression was quantified upon administration of luciferin at several observation times. For oedema and inflammation quantification, wet:dry ratio measurements and a myeloperoxidase assay of the muscle tissue were performed. Laser Doppler imaging showed that ischaemia was present and that the blood flow had returned to baseline levels after 24 h of reperfusion. VEGFR-2 expression levels in the fibrin + 200 ng VEGF were significantly higher than in all other groups. Granulocyte infiltration was reduced in both treatment groups, as well as reduced oedema formation. These results showed that VEGF released from fibrin had a positive effect on early I-R outcome in a mouse model, possibly via VEGFR-2. Copyright © 2016 John Wiley & Sons, Ltd.

UHPLC‐Q‐TOF MS‐Based Metabolic Analysis for the Therapeutic Efficacy of “Xuebijing Injection” against Sepsis‐Induced Acute Lung Injury

“…Inflammatory mediators, such as ICAM and VCAM, block the microvessels and lead to activation of leukocytes to release inflammatory mediators. These mediators can also release a large amount of oxygen free radicals [ 22 , 23 ]. What is more, ICAM and VCAM are the mediators after the stimulation of TNF- α , IL-1, and endotoxin, leading to adhesion, aggregation, rolling, and exudation of leukocytes [ 24 ].…”

“…Annette et al [ 23 ] found that, in the process of oxidative stress, the amount of xanthine oxidase would be enhanced significantly. The xanthine oxidase (XO) could break down hypoxanthine and xanthine to uric acid and release superoxide, which is consistent with our experimental result.…”

The Effect of Dexmedetomidine on Oxidative Stress Response Following Cerebral Ischemia-Reperfusion in Rats and the Expression of Intracellular Adhesion Molecule-1 (ICAM-1) and S100B

“…The pathophysiological process of ischemia-reperfusion injury is complicated, with potent roles played by oxidative stress response and acute inflammatory response [ 5 , 6 ]. Inflammatory mediators, such as intracellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor-α (TNF-α), can aggravate and block micro-vessels, further leading to the release of inflammatory mediators and cytokines by activating leukocytes, and exerting secondary neuron damage under the direction of oxygen free radicals [ 7 , 8 ]. Nuclear factor kappa B (NF-κB) has pluripotent modulatory roles, and can modulate gene expression levels of various inflammatory mediators, cytokines, and chemotactic factors such as interleukn-8 (IL-8), IL-6, and ICAM, thus playing an important role in cell inflammation and apoptosis.…”

The influence of adipocyte-derived stem cells (ASCs) on the ischemic epigastric flap survival in diabetic rats

“…These findings were similar to the literature review by Foroglou et al 6 It showed an association of ASCs increased the vascular density and the surgical flap viability and cytokines (Vegf-a). In addition, Moritz et al 17 injected Vegf in surgical flaps submitted to ischemia-reperfusion and compared it with placebo. This experiment showed the positive effect of the Vegf-a cytokine on the viability of ischemic surgical flap 10 .…”